Conivaptan
A vasopressin receptor antagonist used in the treatment of hyponatremia
Conivaptan is a vasopressin receptor antagonist used primarily in the treatment of hyponatremia, a condition characterized by low levels of sodium in the blood. It is particularly effective in cases of euvolemic and hypervolemic hyponatremia, which are often associated with conditions such as syndrome of inappropriate antidiuretic hormone secretion (SIADH), congestive heart failure, and cirrhosis.
Mechanism of Action[edit | edit source]
Conivaptan works by antagonizing the effects of vasopressin, a hormone that regulates water balance in the body. It specifically blocks the V1A and V2 subtypes of vasopressin receptors. The V2 receptor is primarily responsible for the antidiuretic effects of vasopressin in the kidneys, promoting water reabsorption. By inhibiting this receptor, conivaptan increases the excretion of free water, thereby correcting the sodium imbalance without causing significant loss of electrolytes.
Pharmacokinetics[edit | edit source]
Conivaptan is administered intravenously, as it has poor oral bioavailability. It is extensively metabolized in the liver, primarily by the cytochrome P450 enzyme CYP3A4. The drug and its metabolites are excreted in the urine and feces. The half-life of conivaptan is approximately 5 to 8 hours, allowing for continuous infusion or repeated dosing to maintain therapeutic levels.
Clinical Use[edit | edit source]
Conivaptan is indicated for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients. It is not recommended for use in patients with hypovolemic hyponatremia, as it may exacerbate the condition. The drug is typically administered as a continuous intravenous infusion over several days, with careful monitoring of serum sodium levels to avoid overly rapid correction, which can lead to osmotic demyelination syndrome.
Adverse Effects[edit | edit source]
Common side effects of conivaptan include infusion site reactions, hypotension, hypokalemia, and headache. Due to its metabolism by CYP3A4, conivaptan can interact with other drugs that are substrates, inhibitors, or inducers of this enzyme, necessitating careful consideration of potential drug interactions.
Contraindications[edit | edit source]
Conivaptan is contraindicated in patients with known hypersensitivity to the drug or its components. It should not be used in patients with hypovolemic hyponatremia or in those with anuria. Caution is advised in patients with hepatic or renal impairment, as these conditions may affect the drug's metabolism and excretion.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD